Pages that link to "Q24652253"
Jump to navigation
Jump to search
The following pages link to Acquired pure red cell aplasia: updated review of treatment (Q24652253):
Displaying 50 items.
- Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance (Q26743454) (← links)
- A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: response to rituximab and cyclophosphamide (Q33397611) (← links)
- Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant (Q33417439) (← links)
- A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia (Q33439333) (← links)
- Recurrent severe anaemia: a rare presentation of parvovirus b19 infection (Q33783400) (← links)
- Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis (Q34122035) (← links)
- Acquired pure red cell aplasia in a patient of rheumatoid arthritis (Q34316187) (← links)
- STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia (Q35051957) (← links)
- Anemia of Central Origin (Q36784115) (← links)
- Dapsone-induced pure red cell aplasia and cholestatic jaundice: A new experience for diagnosis and management (Q37137765) (← links)
- Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A. (Q37558805) (← links)
- Immunosuppressive therapies in the management of immune‐mediated marrow failures in adults: where we stand and where we are going (Q37813788) (← links)
- Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review. (Q37822450) (← links)
- Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. (Q37843939) (← links)
- Corticosteroid treatment of pure red cell aplasia in a patient with hepatitis A. (Q38012974) (← links)
- Overlooked non-motor symptoms in myasthenia gravis (Q38061891) (← links)
- Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab). (Q38065877) (← links)
- Selected emerging diseases in ferrets (Q38104075) (← links)
- Pure red cell aplasia and associated thymoma (Q38678564) (← links)
- Carbamazepine-induced Red Blood Cell Aplasia: A Case Report (Q38757124) (← links)
- Post renal transplant pure red cell aplasia-is tacrolimus a culprit? (Q38914693) (← links)
- Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia (Q39851542) (← links)
- Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia. (Q39927825) (← links)
- Pure red cell aplasia and myasthenia gravis: a patient having both autoimmune conditions in the absence of thymoma (Q40046763) (← links)
- Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group (Q41162138) (← links)
- Pure red cell aplasia in a three-months-old infant possibly secondary to cytomegalo virus infection (Q41693764) (← links)
- Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant (Q41764094) (← links)
- Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine. (Q41821604) (← links)
- Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C (Q41874865) (← links)
- Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab. (Q41887039) (← links)
- Pegylated feline granulocyte colony-stimulating factor increases neutrophil levels in cats (Q42222535) (← links)
- Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report (Q42596400) (← links)
- Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report (Q43185136) (← links)
- Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone (Q44198225) (← links)
- Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children (Q45353058) (← links)
- Hepatitis E virus-related acute liver failure associated with pure red cell aplasia. (Q45363015) (← links)
- Effective treatment of Waldenström macroglobulinemia associated pure red cell aplasia with standard antilymphomatous chemotherapy. (Q46137156) (← links)
- Rational management approach to pure red cell aplasia (Q47584782) (← links)
- Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant (Q48098399) (← links)
- Clinical analysis of 32 patients with acquired pure red cell aplasia (Q49968805) (← links)
- Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia (Q50445553) (← links)
- Pure red cell aplasia due to anti-erythropoietin antibodies or isoniazid? A case report from a 94-year-old man. (Q50453408) (← links)
- Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA). (Q50462318) (← links)
- Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab (Q50493924) (← links)
- The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia (Q50506212) (← links)
- Clinical Use of Cyclosporine as an Adjunctive Therapy in the Management of Feline Idiopathic Pure Red Cell Aplasia (Q50526614) (← links)
- Inflammatory breast cancer and secondary Pure Red Cell Aplasia (Q50536495) (← links)
- Mast cell activation disorder masquerading as pure red cell aplasia (Q50575855) (← links)
- Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit? (Q50597195) (← links)
- Chronic lymphocytic leukemia-associated pure red cell aplasia (Q50606472) (← links)